Clinical trial
A Phase Ib/II Study to Evaluate Safety and Efficacy of Atezolizumab Combined With Radio-chemotherapy in a Preoperative Setting for Patients With Localized Rectal Cancer
NCT03127007 is registered in ClinicalTrials.gov with Grand Hôpital de Charleroi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase Ib/II Study to Evaluate Safety and Efficacy of Atezolizumab Combined With Radio-chemotherapy in a Preoperative Setting for Patients With Localized Rectal Cancer
- Lead sponsor
- Grand Hôpital de Charleroi
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- April 27, 2017
- Completion date
- October 15, 2024
- Enrollment
- 45 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.